Iradimed (IRMD) Asset Writedowns and Impairment (2014 - 2026)
Iradimed (IRMD) reported Asset Writedowns and Impairment of $40000.0 for Q1 2026, up 366.67% year-over-year from $8571.4 in Q1 2025, and up 4671.43% quarter-over-quarter from -$875.0 in Q4 2025.
Iradimed (IRMD) Asset Writedowns and Impairment (2014 - 2026) Analysis & Trends
Iradimed (IRMD) has 13 years of Asset Writedowns and Impairment data on file, last reported at $40000.0 in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $40000.0, up 366.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$29000.0 (up 59.61% YoY), and the FY2025 annual result was -$84000.0, up 11.58% from the prior year.
- Asset Writedowns and Impairment climbed to $40000.0 in Q1 2026 per IRMD's latest filing, from -$875.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $180788.0 in Q1 2023 and troughed at -$109925.0 in Q3 2024.
- A 5-year average of $8541.8 and a median of -$875.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2023 and 2024: Asset Writedowns and Impairment surged 4185.09% in 2023, then slumped 309.2% in 2024.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $73540.0 in 2022, then tumbled by 152.33% to -$38485.0 in 2023, then surged by 90.64% to -$3602.0 in 2024, then surged by 75.71% to -$875.0 in 2025, then jumped by 4671.43% to $40000.0 in 2026.
- Business Quant data shows IRMD's Asset Writedowns and Impairment at $40000.0 in Q1 2026, -$875.0 in Q4 2025, and -$50236.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Iradimed | 1.18 Bn | 1.12 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40,000.00 |
| Mar 31, 2026 | 40,000.00 |
| Dec 31, 2025 | -875.00 |
| Dec 31, 2025 | -875.00 |
| Sep 30, 2025 | -50,236.00 |
| Sep 30, 2025 | -50,236.00 |
| Jun 30, 2025 | -17,889.00 |
| Jun 30, 2025 | -17,889.00 |
| Mar 31, 2025 | -15,000.00 |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | -3,602.00 |
| Dec 31, 2024 | -3,602.00 |
| Sep 30, 2024 | -109,925.00 |
| Sep 30, 2024 | -109,925.00 |
| Jun 30, 2024 | 56,734.00 |
| Jun 30, 2024 | 56,734.00 |
| Mar 31, 2024 | -38,207.00 |
| Mar 31, 2024 | -38,207.00 |
| Dec 31, 2023 | -38,485.00 |
| Dec 31, 2023 | -38,485.00 |